Testing effectiveness (Phase 2)Active Not RecruitingNCT05250973
What this trial is testing
Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis
Who this might be right for
Amyloidosis
Janssen Research & Development, LLC 151